CareTrust REIT, Inc. (CTRE) — closed signal from November 18, 2025
Target reached Published before the outcome was known, scored automatically when the window closed on February 16, 2026.
Predicted vs. what happened
What happened
Hit or exceeded the predicted growth inside the window.
The thesis — published November 18, 2025
Latest quarter showed profit per share from operations up 18%, and the company put $495M to work in new deals, showing real momentum. Price action looks healthy: lots more people are buying than usual, and the recent average price is trending up. Many healthcare property stocks still trade below the value of their real estate, so as borrowing costs steady, investors may favor stronger names like this over the next 0-3 months.
Primary drivers
- 18% rise in cash-style earnings per share shows business is strengthening
- $495M of new deals expands future rent, adds tenants, and supports growth
- Price signals are firm: more buyers than usual and a rising recent average price
- If rates calm, shares may move closer to underlying property values
How it played out
CTRE: the target was not reached
Lyra published CTRE at $36.51 on 2025-11-18 with expected growth of 12%. The thesis pointed to an 18% rise in cash-style earnings per share, $495M of new deals, firmer price signals, and the chance that calmer rates would help stronger healthcare property stocks move closer to property values.
Inside the window, CTRE rose but did not reach the $40.52 target. The peak was $40.5 on 2026-02-13, with a peak gain of 10.9%. It ended the window at $40.01 on 2026-02-16. The thesis partially played out. Price moved in the expected direction, but it stayed below the target.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.